Circulating tumor cell proportion scoring (CTPS) based PD-L1 assessment and clinical application of circulating tumor cells (CTCs) on stage IV non-small cell lung cancer (NSCLC) through liquid biopsy.

Mi-Young Choi,Da Hye Moon,Jong-Min Jo,Hae-Ung Lee,Seri Park,Byung-Hee Jeon,Chang-Min Choi

Circulating tumor cell proportion scoring (CTPS) based PD-L1 assessment and clinical application of circulating tumor cells (CTCs) on stage IV non-small cell lung cancer (NSCLC) through liquid biopsy.

2021

Mi-Young Choi
Da Hye Moon
Jong-Min Jo
Hae-Ung Lee
Seri Park
Byung-Hee Jeon
Chang-Min Choi

e15031Background: Stage IV lung cancer is the most advanced lung cancer state accompanied by metastasized to the area around the lungs or distant major organs. The most common type of lung cancer i...

Keywords:

Cancer research
Lung cancer
PD-L1
Medicine
Liquid biopsy
Stage IV non-small cell lung cancer
stage iv
Circulating tumor cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations